![Euroapi Company Header](https://www.pharmacompass.com/image/flap/euroapi-corp-ad-w30-desktop-header-1-2gif-57087.gif)
![Euroapi Company Header](https://www.pharmacompass.com/image/flap/euro-api-mob-header-w30gif-19381.gif)
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
https://www.globenewswire.com/news-release/2024/07/10/2910984/0/en/Quell-Therapeutics-Appoints-Experienced-Biopharma-Leader-Luke-Beshar-as-Independent-Chair-of-its-Board-of-Directors.html
https://www.globenewswire.com/news-release/2024/06/04/2893353/0/en/Quell-Therapeutics-Advances-QEL-001-its-Multi-modular-Engineered-CAR-Treg-Cell-Therapy-into-Efficacy-Cohort-of-LIBERATE-Phase-1-2-Trial-in-Liver-Transplant-Patients.html
https://www.globenewswire.com/news-release/2024/05/02/2874034/0/en/Quell-Therapeutics-Highlights-Clinical-Potential-of-QEL-001-and-its-Multi-Modular-Treg-Cell-Therapy-Platform-at-the-American-Society-of-Gene-and-Cell-Therapy-ASGCT-27th-Annual-Meet.html
https://www.reuters.com/business/healthcare-pharmaceuticals/astrazeneca-signs-2-bln-agreement-with-quell-develop-cell-therapies-2023-06-09/
https://www.globenewswire.com/news-release/2023/06/09/2685293/0/en/Quell-Therapeutics-Signs-a-Collaboration-Exclusive-Option-and-License-Agreement-with-AstraZeneca-to-Develop-Manufacture-and-Commercialize-Engineered-Treg-Cell-Therapies-for-Autoimm.html
https://www.prnewswire.com/news-releases/quell-therapeutics-to-present-at-upcoming-investor-conferences-in-2022-301685112.html
https://www.prnewswire.com/news-releases/quell-therapeutics-appoints-luke-devey-bmbch-phd-as-chief-medical-officer-301682975.html
http://www.pharmafile.com/news/626274/quell-therapeutics-and-cellistic-collaborate-develop-t-regulatory-cell-therapy-platform
https://www.fiercebiotech.com/biotech/next-gen-car-player-quell-therapeutics-drives-into-fast-lane-major-156m-round
https://www.prnewswire.com/news-releases/quell-therapeutics-raises-156-million-in-oversubscribed-series-b-financing-to-advance-its-pioneering-multi-modular-engineered-t-regulatory-treg-cell-therapy-pipeline-and-platform-301432188.html